Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis in comparison with other rheumatic diseases; a nephrology point of view
Journal of Nephropharmacology · 2017
DOI: 10.15171/npj.2017.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nephropharmacology, 2017. Verfasst von Alireza Sadeghi und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sadeghi, A., Pezeshgi, A., Karimimoghaddam, A., Moghimi, M., Kamali, K., Naseri, M., & Esmaeilzadeh, A. (2017). Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis in comparison with other rheumatic diseases; a nephrology point of view. Journal of Nephropharmacology. https://doi.org/10.15171/npj.2017.12
Vancouver
Sadeghi A, Pezeshgi A, Karimimoghaddam A, Moghimi M, Kamali K, Naseri M, et al. Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis in comparison with other rheumatic diseases; a nephrology point of view. Journal of Nephropharmacology. 2017. doi:10.15171/npj.2017.12
BibTeX
@article{Sadeghi2017,
author = {Sadeghi, Alireza and Pezeshgi, Aiyoub and Karimimoghaddam, Arezoo and Moghimi, Minoosh and Kamali, Koorosh and Naseri, Mahsa and Esmaeilzadeh, Abdolreza},
title = {Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis in comparison with other rheumatic diseases; a nephrology point of view},
journal = {Journal of Nephropharmacology},
year = {2017},
doi = {10.15171/npj.2017.12}
}
EUVIMED